Tina Kimbell

Executive Therapeutic Sales Representative- Neurology at Sunovion Pharmaceuticals - Marlborough, Massachusetts, US

Tina Kimbell's Colleagues at Sunovion Pharmaceuticals
Deborah Schaefer

Executive Therapeutic Specialist, Neuroscience

Contact Deborah Schaefer

Jeff Stemen

Executive Therapeutic Specialist

Contact Jeff Stemen

Rhonda Day

Therapeutic Specialist - Psychiatry

Contact Rhonda Day

Debbie Geline

Senior Therapeutic Specialist, Psychiatry

Contact Debbie Geline

Greg MBA

Long-Term Care Account Specialist, Managed Markets

Contact Greg MBA

Mark MBA

Therapeutic Specialist CNS

Contact Mark MBA

Tonya Jonswold

Therapeutic Specialist, Neurology

Contact Tonya Jonswold

View All Tina Kimbell's Colleagues
Tina Kimbell's Contact Details
HQ
(508) 481-6700
Location
Company
Sunovion Pharmaceuticals
Tina Kimbell's Company Details
Sunovion Pharmaceuticals logo, Sunovion Pharmaceuticals contact details

Sunovion Pharmaceuticals

Marlborough, Massachusetts, US • 1042 Employees
Major Drugs

This page is no longer active or monitored. We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at www.sunovion.com and connect on Twitter and Facebook @Sunovion. LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd. APTIOM is used under license from BIAL. KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc. © 2023 Sunovion Pharmaceuticals Inc. To view our community guidelines, see here: bit.ly/3CozDLX

Neurological Care Pharmaceutical Research Psychiatric Treatments Biopharmaceuticals Medical Innovation Scientific Advancement Therapeutic Activities Drug Development And Manufacturing Clinical Trials Patient Advocacy
Details about Sunovion Pharmaceuticals
Frequently Asked Questions about Tina Kimbell
Tina Kimbell currently works for Sunovion Pharmaceuticals.
Tina Kimbell's role at Sunovion Pharmaceuticals is Executive Therapeutic Sales Representative- Neurology.
Tina Kimbell's email address is ***@sunovion.com. To view Tina Kimbell's full email address, please signup to ConnectPlex.
Tina Kimbell works in the Major Drugs industry.
Tina Kimbell's colleagues at Sunovion Pharmaceuticals are Deborah Schaefer, Jeff Stemen, Rhonda Day, Debbie Geline, Greg MBA, Mark MBA, Tonya Jonswold and others.
Tina Kimbell's phone number is (508) 481-6700
See more information about Tina Kimbell